7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole

C58H80N2S4 — CID 129151110

IUPAC7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole
SMILESCCCCC(CC)CC1(CC(CC)CCCC)c2cc(-c3ccc(C)c4nsnc34)sc2-c2sc3c4c(ccc3c21)-c1sc(C)cc1C4(CC(CC)CCCC)CC(CC)CCCC
InChIInChI=1S/C58H80N2S4/c1-11-19-23-39(15-5)33-57(34-40(16-6)24-20-12-2)46-31-38(10)61-53(46)44-29-30-45-50-56(63-54(45)49(44)57)55-47(32-48(62-55)43-28-27-37(9)51-52(43)60-64-59-51)58(50,35-41(17-7)25-21-13-3)36-42(18-8)26-22-14-4/h27-32,39-42H,11-26,33-36H2,1-10H3
InChIKeyHZFRZAGBEPHBCX-UHFFFAOYSA-N
MW933.56 g/mol
LogP20.27
Rot. Bonds25

About 7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole

7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole (PubChem CID 129151110) has the molecular formula C58H80N2S4 and a molecular weight of 933.56 g/mol. Its IUPAC name is 7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole.

Molecular Properties

Compound Name7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole
PubChem CID129151110
Molecular FormulaC58H80N2S4
Molecular Weight933.56 g/mol
Exact Mass932.52
IUPAC Name7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole
SMILESCCCCC(CC)CC1(CC(CC)CCCC)c2cc(-c3ccc(C)c4nsnc34)sc2-c2sc3c4c(ccc3c21)-c1sc(C)cc1C4(CC(CC)CCCC)CC(CC)CCCC
InChIInChI=1S/C58H80N2S4/c1-11-19-23-39(15-5)33-57(34-40(16-6)24-20-12-2)46-31-38(10)61-53(46)44-29-30-45-50-56(63-54(45)49(44)57)55-47(32-48(62-55)43-28-27-37(9)51-52(43)60-64-59-51)58(50,35-41(17-7)25-21-13-3)36-42(18-8)26-22-14-4/h27-32,39-42H,11-26,33-36H2,1-10H3
InChIKeyHZFRZAGBEPHBCX-UHFFFAOYSA-N
XLogP20.27
TPSA25.78 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds25
Heavy Atoms64
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500933.56
LogP ≤ 520.27
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze 7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole?
The IUPAC name of 7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole (CID 129151110) is 7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole.
What is the SMILES notation for 7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole?
The canonical SMILES for 7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole is CCCCC(CC)CC1(CC(CC)CCCC)c2cc(-c3ccc(C)c4nsnc34)sc2-c2sc3c4c(ccc3c21)-c1sc(C)cc1C4(CC(CC)CCCC)CC(CC)CCCC.
What is the InChIKey of 7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole?
The InChIKey is HZFRZAGBEPHBCX-UHFFFAOYSA-N. The full InChI is InChI=1S/C58H80N2S4/c1-11-19-23-39(15-5)33-57(34-40(16-6)24-20-12-2)46-31-38(10)61-53(46)44-29-30-45-50-56(63-54(45)49(44)57)55-47(32-48(62-55)43-28-27-37(9)51-52(43)60-64-59-51)58(50,35-41(17-7)25-21-13-3)36-42(18-8)26-22-14-4/h27-32,39-42H,11-26,33-36H2,1-10H3.
What are the key properties of 7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole?
7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole has a molecular weight of 933.56 g/mol, XLogP of 20.27, 25 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 7-methyl-4-[3,3,14,14-tetrakis(2-ethylhexyl)-6-methyl-7,18,21-trithiahexacyclo[10.9.0.02,9.04,8.013,20.015,19]henicosa-1(12),2(9),4(8),5,10,13(20),15(19),16-octaen-17-yl]-2,1,3-benzothiadiazole is sourced from PubChem (CID 129151110), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).